Across the recent three months, 4 analysts have shared their insights on Xometry XMTR, expressing a variety of opinions spanning from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 1 | 1 | 2 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 1 | 0 | 2 | 0 | 0 |
3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts have set 12-month price targets for Xometry, revealing an average target of $25.5, a high estimate of $30.00, and a low estimate of $21.00. Experiencing a 27.82% decline, the current average is now lower than the previous average price target of $35.33.
Decoding Analyst Ratings: A Detailed Look
The standing of Xometry among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Nicholas Jones | JMP Securities | Maintains | Market Outperform | $30.00 | - |
Karl Keirstead | UBS | Lowers | Neutral | $21.00 | $22.00 |
Matthew Hedberg | RBC Capital | Lowers | Sector Perform | $23.00 | $38.00 |
Bruno Montanari | Goldman Sachs | Lowers | Buy | $28.00 | $46.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Xometry. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Xometry compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Xometry's stock. This comparison reveals trends in analysts' expectations over time.
For valuable insights into Xometry's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Xometry analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
All You Need to Know About Xometry
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of the revenue is earned from the U.S. segment.
Unraveling the Financial Story of Xometry
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Xometry displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately 30.67%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.
Net Margin: Xometry's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -8.23%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Xometry's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -3.17%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Xometry's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -1.5%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Xometry's debt-to-equity ratio is below the industry average. With a ratio of 0.91, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
What Are Analyst Ratings?
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.